Medicare Enrolled

Dr. Keith Rose, M.D.

Pulmonary Disease · Hackensack, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
30 PROSPECT AVE, Hackensack, NJ 07601
5519964149
In practice since 2006 (19 years)
NPI: 1871514661 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rose from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rose? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rose

Dr. Keith Rose is a pulmonary disease specialist in Hackensack, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rose performed 396 Medicare services across 147 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rose received a total of $12,007 from 32 pharmaceutical and/or device companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rose is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 396 Medicare services $12,007 industry payments

Medicare Practice Summary

Medicare Utilization ↗
396
Medicare services
Bottom 18% in NJ for pulmonary disease
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
147
Unique beneficiaries
$166
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
 319 $184 $936
Additional 30 minutes of critical care
This code represents an additional 30 minutes of critical care services provided beyond the initial critical care time period.
 62 $93 $404
Insertion of non-tunneled central venous catheter
A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin.
 15 $72 $772
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.8% high complexity
0.0% medium
96.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$12,007
Total received (2018-2024)
Avg $1,715/year across 7 years
Top 12% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
100
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,650 (80.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,344 (19.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$962
2023
$10,035
2022
$681
2021
$211
2020
$70
2019
$13
2018
$36

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Shionogi Inc
$242
GlaxoSmithKline, LLC.
$177
La Jolla Pharmaceutical Company
$133
Haemonetics Corporation
$121
Mylan Specialty L.P.
$58
Mindray DS USA, Inc.
$47
ABIOMED
$41
Merck Sharp & Dohme LLC
$39
Takeda Pharmaceuticals U.S.A., Inc.
$31
Boston Scientific Corporation
$23
Amgen Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
GENZYME CORPORATION
$16
Top 3 companies account for 57.3% of 2024 payments
All-time payments by company (2018-2024) ›
Verathon Inc.
$9,650
GlaxoSmithKline, LLC.
$249
Shionogi Inc
$242
Boehringer Ingelheim Pharmaceuticals, Inc.
$201
Ambu Inc.
$156
La Jolla Pharmaceutical Company
$133
Haemonetics Corporation
$121
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$112
Mylan Specialty L.P.
$112
Merck Sharp & Dohme LLC
$110
Amgen Inc.
$105
ABIOMED
$99
United Therapeutics Corporation
$96
AstraZeneca Pharmaceuticals LP
$61
Philips Electronics North America Corporation
$55
Grifols USA, LLC
$52
Mindray DS USA, Inc.
$47
Baxter Healthcare
$47
Boston Scientific Corporation
$46
ABBVIE INC.
$32
GENZYME CORPORATION
$31
Takeda Pharmaceuticals U.S.A., Inc.
$31
Paratek Pharmaceuticals, Inc.
$30
Merck Sharp & Dohme Corporation
$27
Medtronic, Inc.
$26
Salvin Dental Specialties, Inc.
$25
Advanced Respiratory, Inc
$23
Integra LifeSciences Corporation
$21
Sunovion Pharmaceuticals Inc.
$18
ZOLL Medical Corporation
$17
AbbVie Inc.
$16
PFIZER INC.
$15
Top 3 companies account for 84.5% of all-time payments
Associated products mentioned in payments ›
(8829) Respiratoriy Care Undiv · (8874) inCourage · ANDEXXA · AREXVY · AVYCAZ · Bronchoscope and Video Laryngoscope · CODMAN CERTAS · DIFICID · DUPIXENT · ELIQUIS · EXALT Model D · FASENRA · Fetroja · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Impella · LINZESS · Life 2000 Ventilation System · LifeVest · NUCALA · NUZYRA · OFEV · PREVYMIS · Prolastin-C Liquid · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · TE7 MAX · TEFLARO · TEG6S HEMOSTASIS SYSTEM · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Utibron · WINREVAIR · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.

Looking for a pulmonary disease specialist in Hackensack?
Compare pulmonary diseases in the Hackensack area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
650
Per 100K population
68.1
County median income
$123,715
Nearest hospital
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Rose is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 12% of NJ peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Rose experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Rose performed 319 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rose receive payments from pharmaceutical companies?
Yes. Dr. Rose received a total of $12,007 from 32 companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rose's costs compare to other pulmonary diseases in Hackensack?
Dr. Rose's average Medicare payment per service is $166. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rose) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Hackensack
Browse pulmonary diseases in Hackensack ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
Verathon Inc. Payments to Doctors
See all physicians who received payments from Verathon Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Shionogi Inc Payments to Doctors
See all physicians who received payments from Shionogi Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →